Pharma major Dr Reddys Laboratories Ltd has received Establishment Inspection Reports (EIRs) from the US Food and Drug Administration (USFDA) for two of its plants.
According to an intimation by the Hyderabad-based company, its Active Pharmaceutical Ingredients (API) plant 3 at Bollarum in Medak district of Telangana and API Hyderabad Plant I at Jinnram Mandal, also in Medak district, have received EIRs from the US Regulator.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.